We are live on ! Find out more
David Einhorn

David Einhorn DME Capital Management

AUM $3.55B Turnover 25%
1-Year Est. Return 15.62%
 

David Einhorn is the founder of Greenlight Capital, a long/short equity firm known for deep fundamental research and high-profile idea presentations. He became widely known for critical short theses and for value-oriented long positions that can diverge sharply from consensus. Einhorn’s quarterly letters and conference talks are still closely read by professional and retail investors alike.

This Fund
S&P 500
This Quarter Est. Return
+17.5%
1 Year Est. Return
+15.62%
3 Year Est. Return
+75.96%
5 Year Est. Return
+244.03%
10 Year Est. Return
+825.24%
AUM
$3.91B
AUM Growth
+$718M
Cap. Flow
+$269M
Cap. Flow %
6.89%
Top 10 Hldgs %
52.84%
Holding
52
New
7
Increased
11
Reduced
11
Closed
6
Avg Time Held
2 years
Top 10 Avg Time Held
2.6 years
Top 20 Avg Time Held
2.1 years

Top Buys

Rank Stock Value
1
VGNT icon
Versigent
VGNT
+$90.8M
2
FBIN icon
Fortune Brands Innovations
FBIN
+$89.8M
3
PYPL icon
PayPal
PYPL
+$64.8M
4
PRMB icon
Primo Brands
PRMB
+$62.7M
5
WBD icon
Warner Bros
WBD
+$60.8M

Top Sells

Rank Stock Value
1
VSXY icon
Victoria's Secret
VSXY
+$105M
2
CNC icon
Centene
CNC
+$57.8M
3
SLM icon
SLM
SLM
+$45M
4
VSNT icon
Versant Media Group
VSNT
+$44.4M
5
PTON icon
Peloton Interactive
PTON
+$43.4M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 36.91%
2 Healthcare 16.5%
3 Industrials 11.95%
4 Energy 10.38%
5 Communication Services 7.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GRBK icon
1
Green Brick Partners
GRBK
$2.42B
$758M 19.39%
9,467,383
– –
2013 Q2
52 quarters
FLR icon
2
Fluor
FLR
$5.59B
$244M 6.24%
4,658,750
-88,600
-2% -$4.34M
2025 Q2
4 quarters
CNR icon
3
Core Natural Resources
CNR
$3.84B
$183M 4.67%
2,283,200
+425,060
+23% +$37.7M
2020 Q4
22 quarters
BHF icon
4
Brighthouse Financial
BHF
$2.35B
$180M 4.6%
2,842,100
– –
2017 Q3
35 quarters
ACHC icon
5
Acadia Healthcare
ACHC
$3.22B
$130M 3.32%
4,400,641
-117,740
-3% -$3.02M
2024 Q4
6 quarters
PENN icon
6
PENN Entertainment
PENN
$2.42B
$125M 3.2%
5,860,270
-184,170
-3% -$3.3M
2024 Q1
9 quarters
FBIN icon
7
Fortune Brands Innovations
FBIN
$5.5B
$123M 3.15%
+2,241,875
New +$89.8M
2026 Q2
0 quarters
PCG icon
8
PG&E
PCG
$30.3B
$112M 2.85%
6,632,852
– –
2025 Q3
3 quarters
CNC icon
9
Centene
CNC
$31.6B
$106M 2.71%
1,651,150
-1,080,660
-40% -$57.8M
2024 Q4
6 quarters
GPK icon
10
Graphic Packaging
GPK
$3.01B
$105M 2.69%
9,953,430
+853,450
+9% +$8.71M
2021 Q2
20 quarters
SNX icon
11
TD Synnex
SNX
$17.3B
$102M 2.61%
381,042
-98,488
-21% -$23.7M
2024 Q4
6 quarters
TEVA icon
12
Teva Pharmaceutical Industries
TEVA
$45.8B
$97.8M 2.5%
2,886,059
-24,670
-0.8% -$822K
2023 Q4
10 quarters
VGNT icon
13
Versigent
VGNT
$2.96B
$95.7M 2.45%
+2,277,640
New +$90.8M
2026 Q2
0 quarters
CPRI icon
14
Capri Holdings
CPRI
$1.81B
$89.5M 2.29%
4,820,118
-110,200
-2% -$2.12M
2024 Q2
8 quarters
BKV icon
15
BKV
BKV
$1.88B
$84.7M 2.17%
3,095,173
+399,630
+15% +$11M
2025 Q4
2 quarters
DHT icon
16
DHT Holdings
DHT
$3.48B
$83.2M 2.13%
5,034,320
-238,450
-5% -$4.26M
2023 Q3
11 quarters
CROX icon
17
Crocs
CROX
$7.07B
$80.7M 2.07%
669,140
– –
2026 Q1
1 quarter
ROIV icon
18
Roivant Sciences
ROIV
$28B
$76.2M 1.95%
2,152,669
– –
2024 Q1
9 quarters
SHC icon
19
Sotera Health
SHC
$4.54B
$73.4M 1.88%
4,135,515
+2,069,835
+100% +$32.6M
2025 Q2
4 quarters
VSNT icon
20
Versant Media Group
VSNT
$4.61B
$69.2M 1.77%
1,922,172
-1,106,443
-37% -$44.4M
2026 Q1
1 quarter
PRMB icon
21
Primo Brands
PRMB
$8.4B
$69M 1.77%
+2,823,660
New +$62.7M
2026 Q2
0 quarters
DCH icon
22
Dauch
DCH
$886M
$67.2M 1.72%
12,395,104
+6,083,754
+96% +$37M
2026 Q1
1 quarter
PYPL icon
23
PayPal
PYPL
$44.3B
$61.5M 1.57%
+1,424,320
New +$64.8M
2026 Q2
0 quarters
HSIC icon
24
Henry Schein
HSIC
$9.23B
$60M 1.54%
718,550
+119,250
+20% +$9.12M
2025 Q4
2 quarters
WBD icon
25
DELISTED
Warner Bros
WBD
$59.9M 1.53%
+2,246,180
New +$60.8M
2026 Q2
0 quarters

Similar funds

David Einhorn's Q2 2026 Portfolio in Review

As of Q2 2026, David Einhorn held 52 positions worth $3.91B, up 23% from $3.19B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

David Einhorn deployed $269M of net new capital in Q2 2026, opening 7 new positions and adding to 11 existing holdings. Its largest new stake was Versigent: 2,277,640 shares worth $95.7M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 37% of assets, down from 37% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Centene, an estimated $57.8M trimmed.

  • David Einhorn's largest Q2 2026 buy was Versigent: 2,277,640 shares worth $95.7M.
  • David Einhorn added most to Core Natural Resources in Q2 2026, an estimated $37.7M increase.
  • David Einhorn's biggest Q2 2026 reduction was Centene, cutting an estimated $57.8M.
  • David Einhorn fully exited Victoria's Secret in Q2 2026, selling an estimated $105M.
  • David Einhorn's ten largest holdings make up 53% of its $3.91B portfolio in Q2 2026.
  • David Einhorn opened 7 new positions and closed 6 in Q2 2026.
  • David Einhorn's portfolio value rose 23% quarter-over-quarter to $3.91B.

Based on DME Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.